Pall FQ4 beats estimates despite a dip in revenue

|About: Pall Corporation (PLL)|By:, SA News Editor

Pall Corp. (PLL +0.5%) put up a better than expected FQ4, but net profit fell 0.7% as total revenue dipped by 1% Y/Y, and its bottom line was dragged down by a loss from discontinued operations.

The company's attributed the weaker sales to softness in its industrial markets, which have been pressured by soft demand.

Earnings beat the Street however, as its biopharmaceuticals business posted strong performance.

Gross margin was flat at 51.5%, as input costs shrank 0.6%.

Looking forward, the company forecasts earnings of between $3.30 to $3.50 per share on revenue growth in the low to mid-single digits. Analysts are looking for $3.48 a share on 5% revenue growth.